Context-aware ranking
Score combinations against a selected disease model, genotype, pathway state, or phenotype.
Translational therapeutics
Project / 03
AI in Drug Combination Discovery
Find high-potential therapeutic combinations by modeling biological context, mechanism, and interaction evidence.
Translational therapeutics
EPM / 03
01 Purpose
Search the combinatorial therapeutic space with biological context—not brute force alone.
A decision-support platform for ranking drug pairs and higher-order combinations across disease models. It integrates molecular networks, perturbation data, pharmacology, and literature signals to create interpretable combination hypotheses.
Narrow a vast search space before screening
Design more focused combination experiments
Connect computational ranking to translational rationale
02 Platform capabilities
Designed around
the decision.
Purpose-built intelligence for the workflow, evidence, and constraints of this research domain.
Interaction intelligence
Evaluate complementary mechanisms, resistance escape, toxicity overlap, and prior evidence.
Explainable hypotheses
Review the mechanistic rationale and evidence supporting each ranked combination.
03 Research workflow
1Define context
2Map mechanisms
3Predict interactions
4Design validation
04 Applications
Where the platform
creates leverage.
Resistance strategies
Find combinations that may block or bypass adaptive resistance mechanisms.
Drug repurposing
Pair approved or investigational assets in new mechanism-driven contexts.
Portfolio strategy
Map combination opportunities around internal assets or high-priority targets.
05 Explore the platform
See what drug combination discovery could unlock for your team.
Share your current research objective and we’ll tailor the conversation around your workflow.